Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

TransMedics (TMDX) Operating Margin (2018 - 2026)

TransMedics has reported Operating Margin over the past 8 years, most recently at 40.26% for Q4 2025.

  • For Q4 2025, Operating Margin fell 4737.0% year-over-year to 40.26%; the TTM value through Dec 2025 reached 3.73%, down 476.0%, while the annual FY2025 figure was 3.73%, 476.0% down from the prior year.
  • Operating Margin for Q4 2025 was 40.26% at TransMedics, down from 16.2% in the prior quarter.
  • Over five years, Operating Margin peaked at 23.24% in Q2 2025 and troughed at 216.61% in Q3 2021.
  • A 5-year average of 35.27% and a median of 13.31% in 2022 define the central range for Operating Margin.
  • Biggest five-year swings in Operating Margin: crashed -15879bps in 2021 and later soared 19502bps in 2022.
  • Year by year, Operating Margin stood at 132.57% in 2021, then surged by 84bps to 21.61% in 2022, then soared by 115bps to 3.21% in 2023, then surged by 122bps to 7.11% in 2024, then plummeted by -667bps to 40.26% in 2025.
  • Business Quant data shows Operating Margin for TMDX at 40.26% in Q4 2025, 16.2% in Q3 2025, and 23.24% in Q2 2025.